The eight prioritized opportunities support the strategy rationale

Solid Oral Dosage Vaccine Institute Vaccine FFF Plasma

Bioequivalence
Biosimilars Sterile Injectables APIs centers

©The Saudi National Industrial Clusters Development Program 0

The eight prioritized opportunities support the strategy rationale
Primary
Technology Opportunity Summary
Rationale

Vaccine
Research, developing and producing vaccines against pandemics • National security
Institute

Fulfill plasma needs related to albumin, immunoglobulin and clotting factors.

Plasma • National security
Requires a national blood collection system to be in place.

Formulation, filling, finish and packaging of vaccines with focus on

Vaccine FFF • Knowledge
pediatric and therapeutic vaccines

Solid Oral Formulation, and packaging of generic SODs for high volume products, top off-
• GDP & Jobs
Dosage patent products and products with shortages

Bio-
Build the required number of bioequivalence centers to ensure that the drugs which
Equivalence • National security
are produced locally are comparable to international standards
Centers
Partial engineering, bulk manufacturing and fill & finish of off-patent
Biosimilars biological drugs with primary focus on insulin analog, autoimmune and • Knowledge
oncology

Sterile Formulation, filling and packaging for chemical drugs and biologics to address
• Knowledge
Injectables segments such as oncology, anti-infectives, cardiovascular and musculoskeletal

Production of APIs that are consumed locally in high volume as well as off patent
APIs • Knowledge
originator drugs

©The Saudi National Industrial Clusters Development Program 1